CNAO
Pavia, Pv, 27100, Italy
Location status: Recruiting
NCT Number: NCT05457595
The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Pavia, Pv, 27100, Italy
Location status: Recruiting
Primary aim: estimate the effect, in terms of clinical response, of carbon ion treatment (CIRT) in patients with lateral pelvic recurrences of gynecological malignancies.
Secondary aims:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CIRT: Planning Target Volume (PTV) will be delivered a total dose of 48-52.8 GyRBE in 12 fractions, 4 fractions per week. Treatment duration 3 weeks.
Treatment lasting more than 5 weeks or cases of treatment with less than 6 fractions in 14 consecutive days will not be accepted.
Other names: CIRT
Time frame: 1 year after treatment
absence of progression disease, in patients with lateral pelvic recurrences of gynecological malignancies
Time frame: 1 year after treatment
complete regression of the tumor lesion
Time frame: 1 year after treatment
Reduction of the tumor volume > 65% of the initial volume
Time frame: 1 year after treatment
Volume between PR and PD
Time frame: 1 year after treatment
Volume increase > 73% of the initial volume.
Time frame: 1 year after treatment
overall survival
Time frame: 1 year after treatment
Tto define acute, intermediate and late toxicities according to Common Terminology Criteria for Adverse Events (CTCAE version 5.0)
Time frame: 1 year after treatment
Progression free survival (PFS) with qualitative evaluation as a narrative of progression
Contact information is provided by the study sponsor or research team.
Amelia Barcellini, MD
CONTACT
Cristina Bono, MSc
CONTACT
CNAO National Center of Oncological Hadrontherapy
Other
Phase II Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
Acronym: CYCLOPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06022029
Bites and Stings, Bladder Cancer
Los Angeles, California, United States
View Trial DetailsNCT03383094
Cancer, Cancer of Head and Neck
Tucson, Arizona, United States
View Trial DetailsNCT06720675
Adenocarcinoma, Carcinoma
Bologna, Italy
View Trial DetailsNCT05461430
Adenocarcinoma, Adenoma
Oakland, California, United States
View Trial Details